nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Dactinomycin—muscle cancer	0.184	0.2	CbGbCtD
Mifepristone—ABCC1—Vincristine—muscle cancer	0.113	0.123	CbGbCtD
Mifepristone—ABCC1—Etoposide—muscle cancer	0.104	0.113	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—muscle cancer	0.0707	0.0769	CbGbCtD
Mifepristone—ABCC1—Methotrexate—muscle cancer	0.0685	0.0745	CbGbCtD
Mifepristone—CYP3A7—Vincristine—muscle cancer	0.0559	0.0608	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0559	0.0608	CbGbCtD
Mifepristone—ABCB1—Dactinomycin—muscle cancer	0.0443	0.0482	CbGbCtD
Mifepristone—CYP3A5—Vincristine—muscle cancer	0.0419	0.0456	CbGbCtD
Mifepristone—CYP3A5—Etoposide—muscle cancer	0.0384	0.0418	CbGbCtD
Mifepristone—ABCB1—Vincristine—muscle cancer	0.0273	0.0297	CbGbCtD
Mifepristone—ABCB1—Etoposide—muscle cancer	0.025	0.0272	CbGbCtD
Mifepristone—ABCB1—Doxorubicin—muscle cancer	0.0171	0.0186	CbGbCtD
Mifepristone—ABCB1—Methotrexate—muscle cancer	0.0165	0.018	CbGbCtD
Mifepristone—CYP3A4—Vincristine—muscle cancer	0.0163	0.0178	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—muscle cancer	0.0161	0.0175	CbGbCtD
Mifepristone—CYP3A4—Etoposide—muscle cancer	0.015	0.0163	CbGbCtD
Mifepristone—AR—scrotum—muscle cancer	0.0105	0.369	CbGeAlD
Mifepristone—CYP3A4—Doxorubicin—muscle cancer	0.0102	0.0111	CbGbCtD
Mifepristone—Musculoskeletal chest pain—Doxorubicin—muscle cancer	0.00105	0.0201	CcSEcCtD
Mifepristone—PGR—smooth muscle tissue—muscle cancer	0.001	0.0354	CbGeAlD
Mifepristone—Erythema nodosum—Doxorubicin—muscle cancer	0.000943	0.018	CcSEcCtD
Mifepristone—AR—smooth muscle tissue—muscle cancer	0.000798	0.0282	CbGeAlD
Mifepristone—AR—renal system—muscle cancer	0.000768	0.0271	CbGeAlD
Mifepristone—NR3C1—embryo—muscle cancer	0.000735	0.026	CbGeAlD
Mifepristone—Rash maculo-papular—Etoposide—muscle cancer	0.000714	0.0137	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.00071	0.0136	CcSEcCtD
Mifepristone—Pain in extremity—Vincristine—muscle cancer	0.000704	0.0135	CcSEcCtD
Mifepristone—PGR—vagina—muscle cancer	0.000698	0.0247	CbGeAlD
Mifepristone—AR—cardiac atrium—muscle cancer	0.000688	0.0243	CbGeAlD
Mifepristone—ABCC1—cardiac atrium—muscle cancer	0.000653	0.0231	CbGeAlD
Mifepristone—PGR—head—muscle cancer	0.000645	0.0228	CbGeAlD
Mifepristone—PGR—testis—muscle cancer	0.000623	0.022	CbGeAlD
Mifepristone—Muscular weakness—Vincristine—muscle cancer	0.000621	0.0119	CcSEcCtD
Mifepristone—AR—tendon—muscle cancer	0.0006	0.0212	CbGeAlD
Mifepristone—NR3C1—smooth muscle tissue—muscle cancer	0.000578	0.0204	CbGeAlD
Mifepristone—ABCC1—tendon—muscle cancer	0.000569	0.0201	CbGeAlD
Mifepristone—CYP3A5—renal system—muscle cancer	0.000561	0.0198	CbGeAlD
Mifepristone—AR—vagina—muscle cancer	0.000556	0.0197	CbGeAlD
Mifepristone—NR3C1—renal system—muscle cancer	0.000556	0.0197	CbGeAlD
Mifepristone—Vaginal haemorrhage—Doxorubicin—muscle cancer	0.000551	0.0105	CcSEcCtD
Mifepristone—ABCC1—vagina—muscle cancer	0.000528	0.0187	CbGeAlD
Mifepristone—AR—head—muscle cancer	0.000514	0.0182	CbGeAlD
Mifepristone—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.000514	0.00983	CcSEcCtD
Mifepristone—Cramp muscle—Etoposide—muscle cancer	0.000514	0.00983	CcSEcCtD
Mifepristone—NR3C1—cardiac atrium—muscle cancer	0.000498	0.0176	CbGeAlD
Mifepristone—AR—testis—muscle cancer	0.000496	0.0175	CbGeAlD
Mifepristone—Chills—Dactinomycin—muscle cancer	0.000489	0.00936	CcSEcCtD
Mifepristone—Connective tissue disorder—Vincristine—muscle cancer	0.000479	0.00916	CcSEcCtD
Mifepristone—ABCC1—testis—muscle cancer	0.000472	0.0167	CbGeAlD
Mifepristone—Angiopathy—Vincristine—muscle cancer	0.000442	0.00846	CcSEcCtD
Mifepristone—Ill-defined disorder—Dactinomycin—muscle cancer	0.00044	0.00843	CcSEcCtD
Mifepristone—Infestation NOS—Etoposide—muscle cancer	0.00044	0.00841	CcSEcCtD
Mifepristone—Infestation—Etoposide—muscle cancer	0.00044	0.00841	CcSEcCtD
Mifepristone—Mediastinal disorder—Vincristine—muscle cancer	0.000439	0.0084	CcSEcCtD
Mifepristone—NR3C1—tendon—muscle cancer	0.000434	0.0153	CbGeAlD
Mifepristone—Malaise—Dactinomycin—muscle cancer	0.000428	0.00819	CcSEcCtD
Mifepristone—Mental disorder—Vincristine—muscle cancer	0.000427	0.00817	CcSEcCtD
Mifepristone—CYP3A4—renal system—muscle cancer	0.000421	0.0149	CbGeAlD
Mifepristone—NR3C1—bone marrow—muscle cancer	0.000421	0.0149	CbGeAlD
Mifepristone—CYP2D6—renal system—muscle cancer	0.000414	0.0146	CbGeAlD
Mifepristone—Back pain—Vincristine—muscle cancer	0.00041	0.00785	CcSEcCtD
Mifepristone—CYP3A5—vagina—muscle cancer	0.000406	0.0143	CbGeAlD
Mifepristone—Myalgia—Dactinomycin—muscle cancer	0.000404	0.00773	CcSEcCtD
Mifepristone—NR3C1—vagina—muscle cancer	0.000403	0.0142	CbGeAlD
Mifepristone—Discomfort—Dactinomycin—muscle cancer	0.000399	0.00764	CcSEcCtD
Mifepristone—ABCB1—embryo—muscle cancer	0.000393	0.0139	CbGeAlD
Mifepristone—Oedema—Dactinomycin—muscle cancer	0.000387	0.00741	CcSEcCtD
Mifepristone—Infection—Dactinomycin—muscle cancer	0.000385	0.00736	CcSEcCtD
Mifepristone—NR3C1—head—muscle cancer	0.000372	0.0132	CbGeAlD
Mifepristone—Rash maculo-papular—Doxorubicin—muscle cancer	0.000371	0.00709	CcSEcCtD
Mifepristone—Anorexia—Dactinomycin—muscle cancer	0.000369	0.00707	CcSEcCtD
Mifepristone—Hypertension—Vincristine—muscle cancer	0.000366	0.00701	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Methotrexate—muscle cancer	0.000362	0.00693	CcSEcCtD
Mifepristone—Myalgia—Vincristine—muscle cancer	0.000361	0.00691	CcSEcCtD
Mifepristone—NR3C1—testis—muscle cancer	0.00036	0.0127	CbGeAlD
Mifepristone—Angiopathy—Etoposide—muscle cancer	0.000358	0.00685	CcSEcCtD
Mifepristone—Mediastinal disorder—Etoposide—muscle cancer	0.000356	0.00681	CcSEcCtD
Mifepristone—Chills—Etoposide—muscle cancer	0.000354	0.00678	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000353	0.00675	CcSEcCtD
Mifepristone—Oedema—Vincristine—muscle cancer	0.000346	0.00662	CcSEcCtD
Mifepristone—Infection—Vincristine—muscle cancer	0.000344	0.00658	CcSEcCtD
Mifepristone—Nervous system disorder—Vincristine—muscle cancer	0.000339	0.00649	CcSEcCtD
Mifepristone—Decreased appetite—Dactinomycin—muscle cancer	0.000337	0.00644	CcSEcCtD
Mifepristone—Fatigue—Dactinomycin—muscle cancer	0.000334	0.00639	CcSEcCtD
Mifepristone—Back pain—Etoposide—muscle cancer	0.000332	0.00636	CcSEcCtD
Mifepristone—Pain—Dactinomycin—muscle cancer	0.000331	0.00634	CcSEcCtD
Mifepristone—Muscle spasms—Etoposide—muscle cancer	0.00033	0.00632	CcSEcCtD
Mifepristone—Anorexia—Vincristine—muscle cancer	0.00033	0.00631	CcSEcCtD
Mifepristone—Hypotension—Vincristine—muscle cancer	0.000323	0.00619	CcSEcCtD
Mifepristone—Feeling abnormal—Dactinomycin—muscle cancer	0.000319	0.00611	CcSEcCtD
Mifepristone—Ill-defined disorder—Etoposide—muscle cancer	0.000319	0.0061	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000317	0.00606	CcSEcCtD
Mifepristone—Hot flush—Doxorubicin—muscle cancer	0.000316	0.00605	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000315	0.00603	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000314	0.006	CcSEcCtD
Mifepristone—Menopausal symptoms—Doxorubicin—muscle cancer	0.000314	0.006	CcSEcCtD
Mifepristone—Insomnia—Vincristine—muscle cancer	0.000313	0.00599	CcSEcCtD
Mifepristone—Malaise—Etoposide—muscle cancer	0.00031	0.00593	CcSEcCtD
Mifepristone—Breast disorder—Methotrexate—muscle cancer	0.000309	0.00591	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000308	0.00589	CcSEcCtD
Mifepristone—Abdominal pain—Dactinomycin—muscle cancer	0.000306	0.00586	CcSEcCtD
Mifepristone—Body temperature increased—Dactinomycin—muscle cancer	0.000306	0.00586	CcSEcCtD
Mifepristone—Hypoglycaemia—Doxorubicin—muscle cancer	0.000303	0.0058	CcSEcCtD
Mifepristone—Decreased appetite—Vincristine—muscle cancer	0.000301	0.00576	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Vincristine—muscle cancer	0.000299	0.00572	CcSEcCtD
Mifepristone—Fatigue—Vincristine—muscle cancer	0.000298	0.00571	CcSEcCtD
Mifepristone—ABCB1—renal system—muscle cancer	0.000298	0.0105	CbGeAlD
Mifepristone—Hypertension—Etoposide—muscle cancer	0.000297	0.00568	CcSEcCtD
Mifepristone—Pain—Vincristine—muscle cancer	0.000296	0.00566	CcSEcCtD
Mifepristone—Constipation—Vincristine—muscle cancer	0.000296	0.00566	CcSEcCtD
Mifepristone—Pain in extremity—Doxorubicin—muscle cancer	0.000296	0.00566	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00029	0.00556	CcSEcCtD
Mifepristone—Discomfort—Etoposide—muscle cancer	0.000289	0.00553	CcSEcCtD
Mifepristone—Hypersensitivity—Dactinomycin—muscle cancer	0.000285	0.00546	CcSEcCtD
Mifepristone—Gastrointestinal pain—Vincristine—muscle cancer	0.000283	0.00542	CcSEcCtD
Mifepristone—Infection—Etoposide—muscle cancer	0.000279	0.00533	CcSEcCtD
Mifepristone—Asthenia—Dactinomycin—muscle cancer	0.000278	0.00532	CcSEcCtD
Mifepristone—CYP2D6—head—muscle cancer	0.000277	0.00979	CbGeAlD
Mifepristone—Abdominal pain—Vincristine—muscle cancer	0.000274	0.00524	CcSEcCtD
Mifepristone—Body temperature increased—Vincristine—muscle cancer	0.000274	0.00524	CcSEcCtD
Mifepristone—Skin disorder—Etoposide—muscle cancer	0.000272	0.00521	CcSEcCtD
Mifepristone—Hypokalaemia—Doxorubicin—muscle cancer	0.000269	0.00515	CcSEcCtD
Mifepristone—CYP2D6—testis—muscle cancer	0.000268	0.00946	CbGeAlD
Mifepristone—Breast disorder—Doxorubicin—muscle cancer	0.000267	0.00512	CcSEcCtD
Mifepristone—Anorexia—Etoposide—muscle cancer	0.000267	0.00511	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000266	0.0051	CcSEcCtD
Mifepristone—Diarrhoea—Dactinomycin—muscle cancer	0.000265	0.00507	CcSEcCtD
Mifepristone—Nasopharyngitis—Doxorubicin—muscle cancer	0.000265	0.00506	CcSEcCtD
Mifepristone—Infestation NOS—Methotrexate—muscle cancer	0.000263	0.00504	CcSEcCtD
Mifepristone—Infestation—Methotrexate—muscle cancer	0.000263	0.00504	CcSEcCtD
Mifepristone—Hypotension—Etoposide—muscle cancer	0.000262	0.00501	CcSEcCtD
Mifepristone—Muscular weakness—Doxorubicin—muscle cancer	0.000261	0.00499	CcSEcCtD
Mifepristone—Hypersensitivity—Vincristine—muscle cancer	0.000255	0.00488	CcSEcCtD
Mifepristone—Dyspnoea—Etoposide—muscle cancer	0.00025	0.00478	CcSEcCtD
Mifepristone—Somnolence—Etoposide—muscle cancer	0.000249	0.00477	CcSEcCtD
Mifepristone—Asthenia—Vincristine—muscle cancer	0.000248	0.00475	CcSEcCtD
Mifepristone—Vomiting—Dactinomycin—muscle cancer	0.000246	0.00471	CcSEcCtD
Mifepristone—Rash—Dactinomycin—muscle cancer	0.000244	0.00467	CcSEcCtD
Mifepristone—Decreased appetite—Etoposide—muscle cancer	0.000244	0.00466	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Etoposide—muscle cancer	0.000242	0.00463	CcSEcCtD
Mifepristone—Fatigue—Etoposide—muscle cancer	0.000242	0.00463	CcSEcCtD
Mifepristone—Pain—Etoposide—muscle cancer	0.00024	0.00459	CcSEcCtD
Mifepristone—Constipation—Etoposide—muscle cancer	0.00024	0.00459	CcSEcCtD
Mifepristone—Haemoglobin—Methotrexate—muscle cancer	0.000238	0.00455	CcSEcCtD
Mifepristone—Diarrhoea—Vincristine—muscle cancer	0.000237	0.00453	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—muscle cancer	0.000236	0.00452	CcSEcCtD
Mifepristone—Feeling abnormal—Etoposide—muscle cancer	0.000231	0.00442	CcSEcCtD
Mifepristone—Nausea—Dactinomycin—muscle cancer	0.00023	0.0044	CcSEcCtD
Mifepristone—Gastrointestinal pain—Etoposide—muscle cancer	0.000229	0.00439	CcSEcCtD
Mifepristone—Dizziness—Vincristine—muscle cancer	0.000229	0.00438	CcSEcCtD
Mifepristone—Infestation NOS—Doxorubicin—muscle cancer	0.000228	0.00436	CcSEcCtD
Mifepristone—Infestation—Doxorubicin—muscle cancer	0.000228	0.00436	CcSEcCtD
Mifepristone—ABCB1—bone marrow—muscle cancer	0.000225	0.00796	CbGeAlD
Mifepristone—Urticaria—Etoposide—muscle cancer	0.000223	0.00426	CcSEcCtD
Mifepristone—Body temperature increased—Etoposide—muscle cancer	0.000222	0.00424	CcSEcCtD
Mifepristone—Abdominal pain—Etoposide—muscle cancer	0.000222	0.00424	CcSEcCtD
Mifepristone—Vomiting—Vincristine—muscle cancer	0.00022	0.00421	CcSEcCtD
Mifepristone—Rash—Vincristine—muscle cancer	0.000218	0.00418	CcSEcCtD
Mifepristone—Dermatitis—Vincristine—muscle cancer	0.000218	0.00417	CcSEcCtD
Mifepristone—Headache—Vincristine—muscle cancer	0.000217	0.00415	CcSEcCtD
Mifepristone—ABCB1—vagina—muscle cancer	0.000216	0.00762	CbGeAlD
Mifepristone—Angiopathy—Methotrexate—muscle cancer	0.000214	0.0041	CcSEcCtD
Mifepristone—Sinusitis—Doxorubicin—muscle cancer	0.000214	0.00409	CcSEcCtD
Mifepristone—Mediastinal disorder—Methotrexate—muscle cancer	0.000213	0.00408	CcSEcCtD
Mifepristone—Chills—Methotrexate—muscle cancer	0.000212	0.00406	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—muscle cancer	0.000207	0.00396	CcSEcCtD
Mifepristone—Hypersensitivity—Etoposide—muscle cancer	0.000207	0.00395	CcSEcCtD
Mifepristone—Malnutrition—Methotrexate—muscle cancer	0.000206	0.00394	CcSEcCtD
Mifepristone—Haemoglobin—Doxorubicin—muscle cancer	0.000206	0.00394	CcSEcCtD
Mifepristone—Nausea—Vincristine—muscle cancer	0.000206	0.00393	CcSEcCtD
Mifepristone—Haemorrhage—Doxorubicin—muscle cancer	0.000205	0.00392	CcSEcCtD
Mifepristone—Oedema peripheral—Doxorubicin—muscle cancer	0.000202	0.00386	CcSEcCtD
Mifepristone—Asthenia—Etoposide—muscle cancer	0.000201	0.00385	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—muscle cancer	0.000201	0.00385	CcSEcCtD
Mifepristone—ABCB1—head—muscle cancer	0.000199	0.00704	CbGeAlD
Mifepristone—Back pain—Methotrexate—muscle cancer	0.000199	0.00381	CcSEcCtD
Mifepristone—Pruritus—Etoposide—muscle cancer	0.000198	0.0038	CcSEcCtD
Mifepristone—ABCB1—testis—muscle cancer	0.000193	0.0068	CbGeAlD
Mifepristone—Diarrhoea—Etoposide—muscle cancer	0.000192	0.00367	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—muscle cancer	0.000191	0.00365	CcSEcCtD
Mifepristone—Angiopathy—Doxorubicin—muscle cancer	0.000186	0.00355	CcSEcCtD
Mifepristone—Malaise—Methotrexate—muscle cancer	0.000186	0.00355	CcSEcCtD
Mifepristone—Dizziness—Etoposide—muscle cancer	0.000185	0.00355	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—muscle cancer	0.000184	0.00353	CcSEcCtD
Mifepristone—Chills—Doxorubicin—muscle cancer	0.000184	0.00351	CcSEcCtD
Mifepristone—Mental disorder—Doxorubicin—muscle cancer	0.000179	0.00343	CcSEcCtD
Mifepristone—Vomiting—Etoposide—muscle cancer	0.000178	0.00341	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—muscle cancer	0.000178	0.00341	CcSEcCtD
Mifepristone—Rash—Etoposide—muscle cancer	0.000177	0.00338	CcSEcCtD
Mifepristone—Dermatitis—Etoposide—muscle cancer	0.000177	0.00338	CcSEcCtD
Mifepristone—Headache—Etoposide—muscle cancer	0.000176	0.00336	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—muscle cancer	0.000175	0.00335	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—muscle cancer	0.000175	0.00335	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000174	0.00333	CcSEcCtD
Mifepristone—Discomfort—Methotrexate—muscle cancer	0.000173	0.00331	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—muscle cancer	0.000172	0.0033	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—muscle cancer	0.000171	0.00328	CcSEcCtD
Mifepristone—Infection—Methotrexate—muscle cancer	0.000167	0.00319	CcSEcCtD
Mifepristone—Nausea—Etoposide—muscle cancer	0.000167	0.00319	CcSEcCtD
Mifepristone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000165	0.00316	CcSEcCtD
Mifepristone—Nervous system disorder—Methotrexate—muscle cancer	0.000165	0.00315	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—muscle cancer	0.000163	0.00312	CcSEcCtD
Mifepristone—Malaise—Doxorubicin—muscle cancer	0.000161	0.00307	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—muscle cancer	0.00016	0.00306	CcSEcCtD
Mifepristone—Hypotension—Methotrexate—muscle cancer	0.000157	0.003	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—muscle cancer	0.000154	0.00294	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000153	0.00293	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—muscle cancer	0.000152	0.00291	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—muscle cancer	0.000152	0.0029	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—muscle cancer	0.000152	0.0029	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—muscle cancer	0.000151	0.00289	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000151	0.00288	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—muscle cancer	0.00015	0.00287	CcSEcCtD
Mifepristone—Dyspnoea—Methotrexate—muscle cancer	0.00015	0.00286	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—muscle cancer	0.000149	0.00286	CcSEcCtD
Mifepristone—Dry mouth—Doxorubicin—muscle cancer	0.000148	0.00284	CcSEcCtD
Mifepristone—Decreased appetite—Methotrexate—muscle cancer	0.000146	0.00279	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—muscle cancer	0.000145	0.00278	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000145	0.00277	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—muscle cancer	0.000145	0.00277	CcSEcCtD
Mifepristone—Infection—Doxorubicin—muscle cancer	0.000144	0.00276	CcSEcCtD
Mifepristone—Pain—Methotrexate—muscle cancer	0.000144	0.00275	CcSEcCtD
Mifepristone—Nervous system disorder—Doxorubicin—muscle cancer	0.000143	0.00273	CcSEcCtD
Mifepristone—Skin disorder—Doxorubicin—muscle cancer	0.000141	0.0027	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—muscle cancer	0.000139	0.00265	CcSEcCtD
Mifepristone—Feeling abnormal—Methotrexate—muscle cancer	0.000138	0.00265	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000137	0.00263	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—muscle cancer	0.000136	0.0026	CcSEcCtD
Mifepristone—Urticaria—Methotrexate—muscle cancer	0.000133	0.00255	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—muscle cancer	0.000133	0.00254	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—muscle cancer	0.000133	0.00254	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000133	0.00254	CcSEcCtD
Mifepristone—Insomnia—Doxorubicin—muscle cancer	0.000132	0.00252	CcSEcCtD
Mifepristone—Dyspnoea—Doxorubicin—muscle cancer	0.00013	0.00248	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—muscle cancer	0.000129	0.00247	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—muscle cancer	0.000126	0.00242	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000126	0.0024	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—muscle cancer	0.000125	0.0024	CcSEcCtD
Mifepristone—Pain—Doxorubicin—muscle cancer	0.000124	0.00238	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—muscle cancer	0.000124	0.00238	CcSEcCtD
Mifepristone—Hypersensitivity—Methotrexate—muscle cancer	0.000124	0.00237	CcSEcCtD
Mifepristone—Asthenia—Methotrexate—muscle cancer	0.000121	0.00231	CcSEcCtD
Mifepristone—Feeling abnormal—Doxorubicin—muscle cancer	0.00012	0.00229	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000119	0.00228	CcSEcCtD
Mifepristone—Pruritus—Methotrexate—muscle cancer	0.000119	0.00227	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—muscle cancer	0.000116	0.00221	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—muscle cancer	0.000115	0.0022	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—muscle cancer	0.000115	0.0022	CcSEcCtD
Mifepristone—Diarrhoea—Methotrexate—muscle cancer	0.000115	0.0022	CcSEcCtD
Mifepristone—Dizziness—Methotrexate—muscle cancer	0.000111	0.00213	CcSEcCtD
Mifepristone—Hypersensitivity—Doxorubicin—muscle cancer	0.000107	0.00205	CcSEcCtD
Mifepristone—Vomiting—Methotrexate—muscle cancer	0.000107	0.00204	CcSEcCtD
Mifepristone—Rash—Methotrexate—muscle cancer	0.000106	0.00203	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—muscle cancer	0.000106	0.00202	CcSEcCtD
Mifepristone—Headache—Methotrexate—muscle cancer	0.000105	0.00201	CcSEcCtD
Mifepristone—Asthenia—Doxorubicin—muscle cancer	0.000104	0.002	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—muscle cancer	0.000103	0.00197	CcSEcCtD
Mifepristone—Nausea—Methotrexate—muscle cancer	9.98e-05	0.00191	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—muscle cancer	9.95e-05	0.0019	CcSEcCtD
Mifepristone—Dizziness—Doxorubicin—muscle cancer	9.62e-05	0.00184	CcSEcCtD
Mifepristone—Vomiting—Doxorubicin—muscle cancer	9.25e-05	0.00177	CcSEcCtD
Mifepristone—Rash—Doxorubicin—muscle cancer	9.17e-05	0.00175	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—muscle cancer	9.16e-05	0.00175	CcSEcCtD
Mifepristone—Headache—Doxorubicin—muscle cancer	9.11e-05	0.00174	CcSEcCtD
Mifepristone—Nausea—Doxorubicin—muscle cancer	8.64e-05	0.00165	CcSEcCtD
